Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymorphic light eruption.

P G Norris1, J L Hawk

  • 1Photobiology Unit, Institute of Dermatology, London, United Kingdom.

Photodermatology, Photoimmunology & Photomedicine
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic actinic dermatitis is not a viable concept-Reply

Archives of dermatology·2014
Same author

Resolution of actinic reticuloid with transition to photosensitive eczema.

Journal of the Royal Society of Medicine·2010
Same author

Case 2.

Clinical and experimental dermatology·2004
Same author

Imiquimod 5% cream in the treatment of mycosis fungoides--a pilot study.

The Journal of dermatological treatment·2004
Same author

Multiple squamous skin carcinomas following excess sunbed use.

Journal of the Royal Society of Medicine·2001
Same author

Tumour necrosis factor alpha promoter polymorphism at position -308 is not associated with actinic prurigo.

Clinical and experimental dermatology·2001
Same journal

Combination Therapy With Microneedle Radiofrequency Followed by Low-Fluence 1064-Nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Melasma: A Case Series.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Primary Cutaneous CD4+ Small/Medium Sized T-Cell Lymphoproliferative Disorder Presenting in the Setting of Chronic Actinic Dermatitis.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Enhancing Photoprotection: Assessing Visible Light Photoprotection in Tinted Inorganic Sunscreens.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Combination of Oral Gliadin-Protected Superoxide Dismutase With Targeted Phototherapy in Vitiligo: A Prospective, Comparative, Randomized, Single-Blinded Study.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Exploring the Impact of Phototherapy on Cardiovascular Events and Survival in Cutaneous T-Cell Lymphoma.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Erlotinib and Leflunomide Disrupt 6-Formylindolo[3,2-b]Carbazole Metabolism and Sensitize Keratinocytes to UVA Radiation-Induced Apoptosis.

Photodermatology, photoimmunology & photomedicine·2026
See all related articles

Polymorphic light eruption (PLE) is a diverse skin condition with unclear causes. Research suggests immune system involvement and UV radiation

Area of Science:

  • Dermatology
  • Photobiology
  • Immunology

Background:

  • Polymorphic light eruption (PLE) presents a wide clinical spectrum with overlapping subgroups, but its pathogenic mechanisms remain poorly understood.
  • The action spectrum for PLE typically involves ultraviolet A (UVA), though some patients primarily react to ultraviolet B (UVB), a diversity that is unexplained.
  • Characteristic features of PLE, such as variable skin susceptibility, higher incidence in temperate climates during spring, and developing tolerance in summer, require explanation by pathogenetic models.

Purpose of the Study:

  • To explore potential pathogenetic mechanisms underlying Polymorphic Light Eruption (PLE).
  • To reconcile the diverse clinical presentations and action spectra of PLE with underlying biological processes.
  • To evaluate the suitability of current subdivisions of PLE in the absence of understood pathogenic mechanisms.

Related Experiment Videos

Main Methods:

  • Review of existing literature on PLE, focusing on clinical observations, action spectra, and proposed pathogenetic models.
  • Analysis of immunohistological findings and keratinocyte ICAM-1 expression in relation to known immune responses.
  • Consideration of treatment responses, including immunosuppression, as evidence for pathogenetic mechanisms.

Main Results:

  • The diversity in PLE action spectra (UVA vs. UVB) and difficulties in artificial lesion induction remain unexplained.
  • An immunological mechanism is proposed, supported by immunohistological similarities to type IV hypersensitivity and positive responses to immunosuppression (e.g., azathioprine) in severe cases.
  • Alternative proposed mechanisms involve abnormal cutaneous arachidonic acid metabolism and excessive leukotriene B4 release following UVA irradiation.

Conclusions:

  • Current understanding of PLE pathogenesis is insufficient to definitively validate its clinical subdivisions.
  • Immunological mechanisms, particularly type IV hypersensitivity-like reactions, are strongly suggested by clinical and histological evidence.
  • Further research into UV-induced immune responses and metabolic pathways is crucial for elucidating PLE pathogenesis.